Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox

Primary cutaneous anaplastic large cell lymphoma (PCALCL) is a rare variant of cutaneous T cell lymphoma (CTCL) characterized by CD30-expressing large atypical cells with kidney-shaped nuclei called hallmark cells. Since PCALCL is a rare variant of CTCL, the treatment of PCALCL is still controversia...

Full description

Bibliographic Details
Main Authors: Mayuko Amagai, Sadanori Furudate, Kentaro Ohuchi, Toshiya Takahashi, Emi Yamazaki, Hiromu Chiba, Yoshihide Asano, Taku Fujimura
Format: Article
Language:English
Published: Karger Publishers 2022-08-01
Series:Case Reports in Oncology
Subjects:
Online Access:https://www.karger.com/Article/FullText/526312
_version_ 1818050157756809216
author Mayuko Amagai
Sadanori Furudate
Kentaro Ohuchi
Toshiya Takahashi
Emi Yamazaki
Hiromu Chiba
Yoshihide Asano
Taku Fujimura
author_facet Mayuko Amagai
Sadanori Furudate
Kentaro Ohuchi
Toshiya Takahashi
Emi Yamazaki
Hiromu Chiba
Yoshihide Asano
Taku Fujimura
author_sort Mayuko Amagai
collection DOAJ
description Primary cutaneous anaplastic large cell lymphoma (PCALCL) is a rare variant of cutaneous T cell lymphoma (CTCL) characterized by CD30-expressing large atypical cells with kidney-shaped nuclei called hallmark cells. Since PCALCL is a rare variant of CTCL, the treatment of PCALCL is still controversial. In this report, a case of PCALCL successfully treated with denileukin diftitox as second-line therapy is described. Interestingly, the administration of denileukin diftitox decreased CD8+ T cells, CD25+ cells, granulysin-bearing lymphocytes, and CD163+ macrophages. The present case suggests that denileukin diftitox might induce an anti-lymphoma effect as well as modulate the tumor microenvironment.
first_indexed 2024-12-10T10:49:01Z
format Article
id doaj.art-4c18d05cfbc04ba99174a9bbf344291b
institution Directory Open Access Journal
issn 1662-6575
language English
last_indexed 2024-12-10T10:49:01Z
publishDate 2022-08-01
publisher Karger Publishers
record_format Article
series Case Reports in Oncology
spelling doaj.art-4c18d05cfbc04ba99174a9bbf344291b2022-12-22T01:52:05ZengKarger PublishersCase Reports in Oncology1662-65752022-08-0115272673110.1159/000526312526312Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin DiftitoxMayuko Amagaihttps://orcid.org/0000-0002-8243-8537Sadanori FurudateKentaro Ohuchihttps://orcid.org/0000-0002-6786-7704Toshiya Takahashihttps://orcid.org/0000-0001-9742-2282Emi YamazakiHiromu ChibaYoshihide AsanoTaku FujimuraPrimary cutaneous anaplastic large cell lymphoma (PCALCL) is a rare variant of cutaneous T cell lymphoma (CTCL) characterized by CD30-expressing large atypical cells with kidney-shaped nuclei called hallmark cells. Since PCALCL is a rare variant of CTCL, the treatment of PCALCL is still controversial. In this report, a case of PCALCL successfully treated with denileukin diftitox as second-line therapy is described. Interestingly, the administration of denileukin diftitox decreased CD8+ T cells, CD25+ cells, granulysin-bearing lymphocytes, and CD163+ macrophages. The present case suggests that denileukin diftitox might induce an anti-lymphoma effect as well as modulate the tumor microenvironment.https://www.karger.com/Article/FullText/526312pcalcldenileukin diftitoxchemotherapytumor-infiltrating cellsgranulysin
spellingShingle Mayuko Amagai
Sadanori Furudate
Kentaro Ohuchi
Toshiya Takahashi
Emi Yamazaki
Hiromu Chiba
Yoshihide Asano
Taku Fujimura
Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
Case Reports in Oncology
pcalcl
denileukin diftitox
chemotherapy
tumor-infiltrating cells
granulysin
title Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
title_full Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
title_fullStr Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
title_full_unstemmed Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
title_short Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
title_sort successful treatment of primary cutaneous anaplastic large cell lymphoma with denileukin diftitox
topic pcalcl
denileukin diftitox
chemotherapy
tumor-infiltrating cells
granulysin
url https://www.karger.com/Article/FullText/526312
work_keys_str_mv AT mayukoamagai successfultreatmentofprimarycutaneousanaplasticlargecelllymphomawithdenileukindiftitox
AT sadanorifurudate successfultreatmentofprimarycutaneousanaplasticlargecelllymphomawithdenileukindiftitox
AT kentaroohuchi successfultreatmentofprimarycutaneousanaplasticlargecelllymphomawithdenileukindiftitox
AT toshiyatakahashi successfultreatmentofprimarycutaneousanaplasticlargecelllymphomawithdenileukindiftitox
AT emiyamazaki successfultreatmentofprimarycutaneousanaplasticlargecelllymphomawithdenileukindiftitox
AT hiromuchiba successfultreatmentofprimarycutaneousanaplasticlargecelllymphomawithdenileukindiftitox
AT yoshihideasano successfultreatmentofprimarycutaneousanaplasticlargecelllymphomawithdenileukindiftitox
AT takufujimura successfultreatmentofprimarycutaneousanaplasticlargecelllymphomawithdenileukindiftitox